X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/eupraxia-pharmaceuticals-announces-gastrointestinal-clinical-advisory-board-302134202.html
https://www.prnewswire.com/news-releases/eupraxia-pharmaceuticals-announces-upcoming-presentations-at-the-osteoarthritis-research-society-international-world-congress-2024-302113903.html
https://www.prnewswire.com/news-releases/eupraxia-pharmaceuticals-to-present-at-bloom-burton--co-healthcare-investor-conference-302109696.html
https://www.prnewswire.com/news-releases/eupraxia-pharmaceuticals-begins-trading-on-nasdaq-today-302109044.html
https://www.prnewswire.com/news-releases/eupraxia-pharmaceuticals-to-begin-trading-on-nasdaq-on-april-5-2024-302107684.html
https://www.prnewswire.com/news-releases/eupraxia-pharmaceuticals-reports-fourth-quarter-and-2023-financial-results-302104855.html
https://www.globenewswire.com//news-release/2024/03/15/2847028/0/en/Eupraxia-Pharmaceuticals-Announces-Closing-of-Overnight-Marketed-Offering-for-Gross-Proceeds-of-C-33-9-Million.html
https://www.globenewswire.com//news-release/2024/03/12/2844646/0/en/Eupraxia-Pharmaceuticals-Announces-Pricing-of-Overnight-Marketed-Offering-of-30-Million.html
https://www.globenewswire.com//news-release/2024/03/11/2844156/0/en/Eupraxia-Pharmaceuticals-Announces-Overnight-Marketed-Offering-of-Approximately-30-Million.html
https://www.prnewswire.com/news-releases/eupraxia-pharmaceuticals-reports-positive-topline-data-in-its-phase-2b-osteoarthritis-trial-with-ep-104iar-301862773.html
Market Place
Share 
